Stability in community-acquired pneumonia: one step forward with markers?

Autores de IIS La Fe

• Rosario Menéndez Villanueva

  Autor

• Rafael Martinez Diaz

  Autor

• Soledad Reyes Calzada

  Autor

• Eva Polverino

  Autor

• Xavier Filella Pla

  Autor

• Antonia Martinez Gasco

  Autor

• Paula Ramírez Galleymore

  Autor

• Antonio Torres Marti

  Autor

Participantes ajenos a IIS La Fe

• Mensa J
• Esquinas C

Grupos

• Infecciones Respiratorias

Abstract

Biological markers as an expression of systemic inflammation have been recognised as useful for evaluating the host response in community-acquired pneumonia (CAP). The objective of this study was to evaluate whether the biological markers procalcitonin (PCT) and C-reactive protein (CRP) might reflect stability after 72 h of treatment and the absence of subsequent severe complications.

Keywords

• C-REACTIVE PROTEIN; INFLAMMATORY MARKERS; HOSPITAL DISCHARGE; FOLLOW-UP; PROCALCITONIN; SEVERITY; OUTCOMES; INSTABILITY; MANAGEMENT; RISK